在胆汁液中Ceftazidime和Avibactam的度-一项前性IIb期研究
Andrea Witowski1, Lars Palmowski1, Iris K Minichmayr2
1Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, D-44892 Bochum, Germany.
The Journal of antimicrobial chemotherapy
|October 7, 2024
概括
塞法胺-阿维巴克坦 (CAZ/AVI) 在胆汁中显示出有希望的度,这表明它对多抗性胆汁感染的有效性. 这项研究为这种重要的抗生素组合提供了关键的药理动力学数据.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 临床微生物学 临床微生物学
背景情况:
- 耐卡巴胺细菌的威胁日益增加,需要新的治疗策略.
- 塞法胺-阿维巴克坦 (CAZ/AVI) 已被批准用于对卡巴耐药的腹内感染.
- 关于阿维巴克坦 (AVI) 在肝胆系统中的药理动力学的数据有限.
研究的目的:
- 在人胆中确定AVI的体内度.
- 为了评估AVI的肝胆排泄概况.
- 在胆道感染的背景下提供CAZ/AVI的临床数据.
主要方法:
- 一项IIb期研究,涉及10名接受单剂CAZ/AVI (2000/500毫克) 的患者.
- 从9名切除后患者收集了胆汁样本.
- 测量了血和胆汁中的抗生素度,以及药理动力学参数.
主要成果:
- 平均胆汁度:CAZ 33.5 毫克/升,AVI 7.1 毫克/升.
- 对于CAZ和AVI的胆汁/血比分别为0.58和0.61.
- 两种药物在血中的治疗度 (T>MIC>50%) 保持不变;没有报告任何不良事件.
结论:
- CAZ/AVI在胆汁中达到显著的度.
- 这些发现支持CAZ/AVI在治疗多抗性胆道感染方面的潜力.
- 需要对胆道感染的CAZ/AVI进行进一步的研究.
相关概念视频
Hepatic Drug Excretion: Influencing Factors
96
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
96
Hepatic Drug Excretion: Enterohepatic Cycling
1.1K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.1K
Hepatic Drug Clearance: Role of Transporters
44
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
44
Drug Concentrations: Measurements
342
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
342
Drug Concentration Versus Time Correlation
660
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
660


